Prednisone and supplements: interactions, cautions, and safe stacks
Prednisone is a prodrug — your liver converts it to the active form, prednisolone, which is then further cleared via CYP3A4. The two big interaction categories are (1) immune modulation (most supplement issues live here, and most are bad-direction interactions for autoimmune or transplant patients) and (2) CYP3A4 modulation, which alters prednisolone exposure. The third bucket — bone protection — is the dominant story for chronic users.
Avoid combiningAvoid
Echinacea is a deliberate immune stimulator — exactly the opposite of what prednisone is doing in autoimmune disease, transplant rejection, or severe inflammatory conditions. For short-course prednisone (a week-long taper for a flare in a healthy person) the practical risk is minor; for chronic immunosuppressed users (lupus, RA, transplant) it directly undermines therapy. Stop during steroid courses for immunological indications. Class default (cortico); upgrade for transplant/autoimmune indication
Astragalus shares the same immune-stimulating mechanism. Particularly counterproductive in autoimmune indications where steroid therapy is intentionally suppressing immune activity. Common in "immune support" stacks marketed for cold/flu prevention — worth asking about explicitly.
High-dose licorice (glycyrrhizin) inhibits 11β-HSD2, which is the enzyme that normally inactivates cortisol in peripheral tissues. The result is potentiation of glucocorticoid effects — compounding Cushingoid features (weight gain, moon face, hypertension, hypokalemia) and worsening the metabolic side-effect burden of prednisone itself. Glycyrrhizin-containing licorice products and traditional decoctions should be off the list during prednisone therapy. DGL (deglycyrrhizinated licorice, used for reflux) is not affected by this warning. PMID 36285406
Caution / watch carefullyCaution
Elderberry, reishi, maitake, beta-glucan, andrographis — all have documented immune-modulating activity (typically immunostimulant). The clinical relevance scales with duration of prednisone therapy and immunological indication. Short courses for non-immunological indications (acute back pain, post-extubation swelling) are unlikely to be meaningfully affected. Long-term steroid users for autoimmune disease or transplant should treat these as default-avoid; short courses warrant a discussion with prescriber.
St John's wort is a strong CYP3A4 inducer and can lower prednisolone AUC by approximately 50%. The most concerning published context is transplant patients losing immunosuppressive cover. For transplant indications, upgrade to AVOID. For short-course prednisone in immunocompetent patients, the risk is loss of efficacy rather than something dangerous. PMID 38025741
Curcumin (bioavailable forms — Meriva, Theracurmin, BCM-95) inhibits CYP3A4, raising prednisolone exposure. Curcumin also has its own anti-inflammatory activity that can complicate the clinician's ability to titrate steroid dose by symptoms. Plain culinary turmeric is not a meaningful issue at culinary intakes. PMID 34182907
Berberine inhibits CYP3A4 (and 2D6) and can raise prednisolone exposure modestly. Common in metabolic-health and lipid-management stacks; flag to prescriber if combined with chronic prednisone.
Potassium replacement is often appropriate on long-term high-dose steroids (steroids cause potassium loss). The watch-out is the same as for diuretics: if also on an ACE inhibitor or ARB, monitor for hyperkalemia rather than assuming replacement is needed.
Watch (mild signals)Watch
Grapefruit produces a modest 1.2–1.5× increase in prednisolone AUC via CYP3A4 inhibition. This is less severe than the dangerous tacrolimus/cyclosporine grapefruit interactions (where AUC can triple), but worth knowing if you drink daily grapefruit juice and notice steroid side-effects at lower-than-expected doses. Occasional small servings are clinically inconsequential. PMID 11963641
Often supportive / recommendedSafe
Calcium at 1000–1200 mg/day elemental — ACR 2022 GIOP recommendation for any patient on ≥2.5 mg/day prednisone-equivalent for ≥3 months. This is replacement, not a risk. Diet first, then supplement to fill the gap. PMID 37845798
Vitamin D3 at 600–1000 IU/day minimum (more if 25-OH-D <30 ng/mL) — ACR 2022 GIOP recommendation. Steroids reduce intestinal calcium absorption and increase urinary calcium loss; vitamin D3 partially offsets both. PMID 37845798
Vitamin K2 (MK-7) 90–180 μg/day is a reasonable adjunctive bone-support strategy during chronic steroid therapy. Not in the formal GIOP guideline but mechanistically supportive.
Magnesium glycinate 200–400 mg elemental/day replaces the modest urinary magnesium loss from chronic steroid therapy. Also helpful for steroid-associated insomnia and muscle cramps.
Zinc at RDA (8–11 mg/day) replaces the modest depletion that occurs with chronic steroid use. Safe and worth including in a multivitamin.
CoQ10 100–200 mg/day may help mitigate steroid-induced myopathy and cardiac side effects; no PK interaction.
Omega-3 (EPA/DHA) 1–2 g/day is a standard adjunct in autoimmune disease — the underlying indication for most chronic prednisone therapy. Anti-inflammatory activity is complementary rather than redundant.
Mechanism — why these supplements matter for prednisone
Three mechanistic categories drive prednisone's supplement profile:
- Immune modulation — prednisone suppresses the immune system; supplements that stimulate it (echinacea, astragalus, immune mushrooms, beta-glucan, andrographis, elderberry) work against the therapeutic intent in autoimmune or transplant indications.
- CYP3A4 modulation — prednisolone is a CYP3A4 substrate. Inducers (St John's wort) lower exposure and cause loss of effect, particularly dangerous in transplant. Inhibitors (curcumin, berberine, grapefruit) raise exposure and increase side-effect burden.
- Glucocorticoid potentiation and side-effect mimicry — high-dose licorice inhibits the enzyme that normally inactivates cortisol, compounding the metabolic side-effect burden (hypertension, hypokalemia, weight gain, Cushingoid features).
- Bone protection — steroids drive bone loss via multiple mechanisms; the ACR 2022 GIOP guideline mandates calcium and vitamin D3 supplementation for chronic users. This is the most actionable supplement category on the page.
Short courses (e.g., 5–7 day prednisone burst for asthma exacerbation) in immunocompetent patients carry meaningfully less interaction risk than chronic immunosuppression. Apply this page primarily to patients on ≥3 weeks of continuous therapy.
What to do if you're already taking prednisone and any of these
For chronic prednisone (≥2.5 mg/d for ≥3 months): start calcium 1000–1200 mg/d and vitamin D3 600–1000 IU/d as default per ACR 2022 GIOP. Stop echinacea, astragalus, high-dose licorice, and immune-stimulating mushroom supplements if your indication is autoimmune or transplant. Discuss any CYP3A4-active supplement (St John's wort, bioavailable curcumin, berberine) with your prescriber — these change prednisolone exposure enough to matter for dose-titration decisions.
For short-course prednisone (a 5–10 day taper for a flare or acute condition): the only must-stop is high-dose licorice. Other items can usually wait until after the taper without meaningful clinical consequence.
For transplant patients on chronic prednisone: assume every supplement is potentially problematic and clear additions with your transplant team before starting. St John's wort and immune-stimulating herbs carry the highest stakes in this population.
Related class context
Prednisone shares its interaction profile with the broader oral-glucocorticoid family — prednisolone, methylprednisolone (Medrol), dexamethasone, hydrocortisone. The bone-protection and immune-supplement rules apply uniformly. Dexamethasone has a stronger CYP3A4-substrate profile than prednisone, so CYP-active supplement interactions are slightly more clinically meaningful for dex. For the full picture of how prednisone compares to the rest of the corticosteroid family, see the corticosteroid class page.
Sources
- Generic manufacturers. Prednisone prescribing information. US FDA label, accessed 2026-05.
- Humphrey MB, et al. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. PMID: 37845798.
- Penninkilampi R, et al. Glycyrrhizin (licorice) and apparent mineralocorticoid excess: a systematic review of clinical case reports. PMID: 36285406.
- Vaclavik J, et al. St John's wort and CYP3A4 induction: clinical interactions with corticosteroids and transplant immunosuppressants. PMID: 38025741.
- Hermann R, Heyder NB. Polyphenol-mediated CYP3A4 inhibition: clinical relevance for corticosteroid exposure. PMID: 34182907.
- Hollander AAMJ, et al. Grapefruit juice and prednisolone pharmacokinetics. PMID: 11963641.
Educational reference, not medical advice. Steroid taper, dose, and indication shape interaction risk significantly. Transplant patients should treat every supplement decision as a transplant-team conversation. Confirm any supplement change with your prescriber or pharmacist before acting on this page.